ÂÜÀòÂÒÂ×

George Addona serves as Senior Vice President and Global Head of Discovery, Preclinical Development, and Translational Medicine at Merck, a position held since September 2008. In this role, George leads multidisciplinary teams across various therapeutic areas including Oncology, Immunology, and Neuroscience, and oversees discovery programs through clinical proof-of-concept. Prior experience includes roles at Novartis Institutes for Biomedical Research, where George held positions from Group Leader to Vice President of Quantitative Biosciences. George's early career includes senior scientist roles at Phylogix and Praecis Pharmaceuticals. Educational qualifications include a Ph.D. in Chemistry from the University of Virginia and postdoctoral training in Biological Chemistry and Molecular Pharmacology at Harvard Medical School.